Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Over the last 12 months, insiders at Ocular Therapeutix, Inc. have bought $12.02M and sold $577,451 worth of Ocular Therapeutix, Inc. stock.
On average, over the past 5 years, insiders at Ocular Therapeutix, Inc. have bought $6.24M and sold $456,144 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SUMMER ROAD LLC (10 percent owner) — $12M. Mattessich Antony C. (President and CEO) — $24,765.
The last purchase of 930,851 shares for transaction amount of $7M was made by SUMMER ROAD LLC (10 percent owner) on 2024‑02‑26.
2024-05-23 | Sale | Dugel Pravin | See Remarks | 21,626 0.0139% | $5.79 | $125,215 | -5.00% | |
2024-05-23 | Sale | Nayak Sanjay | Chief Strategy Officer | 2,274 0.0015% | $5.84 | $13,280 | -5.00% | |
2024-02-26 | SUMMER ROAD LLC | 10 percent owner | 930,851 0.6157% | $7.52 | $7M | -36.87% | ||
2024-02-05 | Sale | Mattessich Antony C. | President and CEO | 19,642 0.0177% | $4.86 | $95,460 | +27.07% | |
2024-02-05 | Sale | Notman Donald | Chief Financial Officer | 6,212 0.0056% | $4.86 | $30,190 | +27.07% | |
2024-02-05 | Sale | Strassburger Philip C. | General Counsel | 6,029 0.0054% | $4.86 | $29,301 | +27.07% | |
2024-02-05 | Sale | Ozden Rabia Gurses | Chief Medical Officer | 6,346 0.0057% | $4.86 | $30,842 | +27.07% | |
2024-02-05 | Sale | White Christopher G | Chief Business Officer | 5,910 0.0053% | $4.86 | $28,723 | +27.07% | |
2024-01-31 | Sale | Mattessich Antony C. | President and CEO | 18,338 0.0168% | $4.95 | $90,773 | +27.88% | |
2024-01-31 | Sale | Notman Donald | Chief Financial Officer | 6,433 0.0059% | $4.95 | $31,843 | +27.88% | |
2024-01-31 | Sale | Strassburger Philip C. | General Counsel | 6,831 0.0063% | $4.95 | $33,813 | +27.88% | |
2024-01-31 | Sale | Ozden Rabia Gurses | Chief Medical Officer | 7,764 0.0071% | $4.95 | $38,432 | +27.88% | |
2024-01-31 | Sale | White Christopher G | Chief Business Officer | 5,147 0.0047% | $4.95 | $25,478 | +27.88% | |
2023-12-14 | SUMMER ROAD LLC | 10 percent owner | 1.54M 1.6722% | $3.25 | $5M | +55.29% | ||
2023-08-30 | Mattessich Antony C. | President and CEO | 6,500 0.0082% | $3.81 | $24,765 | +23.38% | ||
2023-07-07 | Sale | Ozden Rabia Gurses | Chief Medical Officer | 832 0.0011% | $4.93 | $4,102 | -7.92% | |
2023-02-06 | Sale | Mattessich Antony C. | President and CEO | 19,669 0.0255% | $4.24 | $83,397 | +6.12% | |
2023-02-06 | Sale | Notman Donald | Chief Financial Officer | 6,476 0.0084% | $4.24 | $27,458 | +6.12% | |
2023-02-06 | Sale | Strassburger Philip C. | General Counsel | 6,181 0.008% | $4.24 | $26,207 | +6.12% | |
2023-02-06 | Sale | Ozden Rabia Gurses | Chief Medical Officer | 6,416 0.0083% | $4.24 | $27,204 | +6.12% |
SUMMER ROAD LLC | 10 percent owner | 8591401 6.9503% | $6.63 | 31 | 0 | +16.78% |
Dugel Pravin | See Remarks | 833353 0.538% | $6.63 | 0 | 1 | |
Mattessich Antony C. | President and CEO | 588701 0.5341% | $6.63 | 6 | 3 | +1.23% |
Notman Donald | Chief Financial Officer | 195356 0.1772% | $6.63 | 3 | 3 | +9.75% |
Strassburger Philip C. | General Counsel | 161493 0.1465% | $6.63 | 0 | 3 | |
Ozden Rabia Gurses | Chief Medical Officer | 153054 0.1389% | $6.63 | 0 | 4 | |
Nayak Sanjay | Chief Strategy Officer | 178026 0.1149% | $6.63 | 0 | 1 | |
White Christopher G | Chief Business Officer | 123689 0.1122% | $6.63 | 0 | 3 | |
Opaleye Management Inc. | 10 percent owner | 4918500 4.4625% | $6.63 | 2 | 0 | +99.18% |
CHV II, L.P. | 10 percent owner | 2100138 1.9054% | $6.63 | 1 | 0 | +69.82% |
Sawhney Amarpreet | Chairman of the Board | 1056031 0.9581% | $6.63 | 10 | 0 | +25.15% |
Fortune James | Chief Operating Officer | 112060 0.1017% | $6.63 | 0 | 1 | |
LINDSTROM RICHARD L MD | director | 90000 0.0817% | $6.63 | 1 | 1 | <0.0001% |
Ankerud Eric | See Remarks | 78651 0.0714% | $6.63 | 1 | 0 | +69.82% |
SVLSF IV, LLC | 10 percent owner | 61084 0.0554% | $6.63 | 1 | 1 | +69.82% |
Bollag Daniel M | See Remarks | 42100 0.0382% | $6.63 | 2 | 0 | +12.45% |
Heier Jeffrey S. | 39000 0.0354% | $6.63 | 2 | 0 | +22.62% | |
Goldstein Michael H. | Chief Medical Officer | 25686 0.0233% | $6.63 | 2 | 0 | +41.08% |
Hanley Kevin F. | See Remarks | 20000 0.0181% | $6.63 | 2 | 0 | <0.0001% |
Polaris Venture Management Co. V, L.L.C. | 10 percent owner | 13419 0.0122% | $6.63 | 0 | 1 | |
Warden Charles M | 13007 0.0118% | $6.63 | 0 | 2 | ||
Versant Venture Capital III, L.P. | 10 percent owner | 13007 0.0118% | $6.63 | 0 | 2 | |
Williams Leslie J. | director | 4500 0.0041% | $6.63 | 1 | 0 | +3.43% |
PEACOCK BRUCE | director | 0 0% | $6.63 | 0 | 1 |
Summer Road LLC | $130.68M | 9.27 | 14.36M | +87.46% | +$60.97M | 100 | |
Vr Adviser Llc | $116.14M | 8.24 | 12.76M | +64.13% | +$45.38M | 5.64 | |
Deep Track Capital Lp | $115.77M | 8.21 | 12.72M | +37.82% | +$31.77M | 0.53 | |
BlackRock | $73.38M | 5.21 | 8.06M | +39.96% | +$20.95M | <0.01 | |
The Vanguard Group | $65.84M | 4.67 | 7.24M | +41.36% | +$19.26M | <0.01 | |
Avoro Capital Advisors Llc | $65.06M | 4.62 | 7.15M | New | +$65.06M | 0.78 | |
Opaleye Management Inc | $60.54M | 4.3 | 6.65M | +9.61% | +$5.31M | 9.56 | |
Logos Global Management Lp | $51.99M | 3.75 | 5.81M | +45.29% | +$16.21M | 5.58 | |
Citadel Advisors LLC | $48.42M | 3.5 | 5.42M | +53.3% | +$16.83M | 0.03 | |
Tcg Crossover Management Llc | $48.4M | 3.43 | 5.32M | New | +$48.4M | 0.08 | |
Perceptive Advisors | $30.25M | 2.15 | 3.32M | New | +$30.25M | 0.02 | |
ACUTA CAPITAL PARTNERS LLC | $23.98M | 1.7 | 2.64M | +101.17% | +$12.06M | 15.58 | |
Geode Capital Management | $22.63M | 1.61 | 2.49M | +43.14% | +$6.82M | <0.01 | |
Octagon Capital Advisors LP | $22.07M | 1.57 | 2.42M | New | +$22.07M | 2.89 | |
State Street | $21.86M | 1.55 | 2.4M | +56.04% | +$7.85M | <0.01 | |
Deltec Asset Management | $21.51M | 1.53 | 2.36M | -3.25% | -$723,659.29 | 4.28 | |
Franklin Templeton Investments | $19.73M | 1.4 | 2.17M | -51.82% | -$21.22M | 0.01 | |
Great Point Partners | $15.73M | 1.12 | 1.73M | +146.96% | +$9.36M | 2.64 | |
Morgan Stanley | $12.49M | 0.89 | 1.37M | +324.88% | +$9.55M | <0.01 | |
Nuveen | $11.04M | 0.78 | 1.21M | +19.84% | +$1.83M | <0.01 | |
Voloridge Investment Management, LLC | $9.89M | 0.7 | 1.09M | New | +$9.89M | 0.02 | |
Northern Trust | $8.83M | 0.63 | 970,098 | +44.36% | +$2.71M | <0.01 | |
Deutsche Bank | $7.26M | 0.52 | 797,528 | +2,202.4% | +$6.94M | <0.01 | |
Invesco | $7.03M | 0.5 | 772,366 | +249.44% | +$5.02M | <0.01 | |
Artia Global Partners Lp | $6.59M | 0.47 | 724,685 | +64.7% | +$2.59M | 1.63 | |
Cetera Advisors LLC | $6.58M | 0.47 | 723,490 | +1,454.99% | +$6.16M | 0.05 | |
T. Rowe Price | $6.03M | 0.43 | 662,672 | +1,142.26% | +$5.55M | <0.01 | |
AXA | $5.81M | 0.41 | 638,305 | +0.03% | +$1,628.90 | 0.02 | |
UBS | $4.4M | 0.31 | 483,506 | +432.3% | +$3.57M | <0.01 | |
Sio Capital Management LLC | $3.49M | 0.25 | 383,026 | -60.57% | -$5.35M | 1.23 | |
ESSEX INVESTMENT MANAGEMENT CO LLC | $3.42M | 0.24 | 376,200 | +1.57% | +$53,034.80 | 0.68 | |
Adage Capital Partners Gp L L C | $3.41M | 0.24 | 375,000 | New | +$3.41M | 0.01 | |
Group One Trading | $3.4M | 0.24 | 373,303 | +740.79% | +$2.99M | 0.1 | |
Barclays | $3.29M | 0.23 | 361,093 | +227.95% | +$2.28M | <0.01 | |
Cubist Systematic Strategies | $3.06M | 0.22 | 336,132 | New | +$3.06M | 0.03 | |
BNY Mellon | $3.01M | 0.21 | 331,252 | +36.12% | +$799,808.31 | <0.01 | |
Charles Schwab | $2.85M | 0.2 | 313,036 | +41.52% | +$835,689.52 | <0.01 | |
Wellington Management Company | $2.47M | 0.18 | 270,918 | New | +$2.47M | <0.0001 | |
Goldman Sachs | $2.45M | 0.17 | 269,181 | +207.45% | +$1.65M | <0.0001 | |
Jane Street Capital | $2.3M | 0.16 | 252,356 | +92.48% | +$1.1M | <0.01 | |
Bank of America | $2.07M | 0.15 | 227,053 | +161.01% | +$1.27M | <0.0001 | |
Santander Group | $1.89M | 0.13 | 208,196 | -61.48% | -$3.02M | 0.02 | |
Tupelo Capital Management LLC | $1.82M | 0.13 | 200,400 | 0% | +$0 | 1.19 | |
Raymond James Associates | $1.77M | 0.13 | 195,033 | +51.17% | +$600,791.00 | <0.01 | |
Susquehanna International Group | $1.78M | 0.13 | 195,517 | +81.63% | +$799,617.14 | <0.01 | |
Nottingham Advisors Asset Management | $1.76M | 0.13 | 193,266 | -0.52% | -$9,100.00 | 0.23 | |
Ubs Oconnor Llc | $1.72M | 0.12 | 188,578 | -43.22% | -$1.31M | 0.15 | |
Millennium Management LLC | $1.54M | 0.11 | 169,331 | -78.16% | -$5.51M | <0.01 | |
D. E. Shaw & Co. | $1.46M | 0.1 | 160,142 | -59.03% | -$2.1M | <0.01 | |
RhumbLine Advisers | $1.38M | 0.1 | 151,956 | +33.34% | +$345,715.70 | <0.01 |